CPAP for obstructive sleep apnea and the metabolic syndrome [3]

New England Journal of Medicine

Volumn 366, Issue 10, 2012, Pages 964-

  Drager, Luciano F ^a   Lorenzi Filho, Geraldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; DISEASE ASSOCIATION; HUMAN; INTRAABDOMINAL FAT; LETTER; METABOLIC SYNDROME X; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SOMNOLENCE; THERAPY EFFECT; TREATMENT OUTCOME; FEMALE; MALE; NOTE;

CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; SLEEP APNEA, OBSTRUCTIVE;

EID: 84857846862     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 2010;5(8):e12065.
2. Drager LF, Bortolotto LA, Maki-Nunes C, et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010;208:490-5.
3. Drager LF, Li J, Reinke C, Bevans-Fonti S, Jun JC, Polotsky VY. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 2011;19:2167-74.
4. Jun JC, Drager LF, Najjar SS, et al. Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep 2011;34:1207-13.